Minimally invasive monitoring of clozapine: Correlation between dried blood spots and serum concentrations – a pilot study
Authors:
- Marta PelcováMPMarta Pelcová
- Juraj SzilágyiJSJuraj Szilágyi
- Viktória ĎurčováVĎViktória Ďurčová
- Pavel ŠmakPŠPavel Šmak
- OndřEj PešOPOndřEj Peš
- Libor UstohalLULibor Ustohal
- Zdeněk GlatzZGZdeněk Glatz
- Jan JuřIcaJJJan JuřIca
Open Access
- 27 June 2026
- journal article
- Published by Elsevier in Journal of Chromatography Open
- Vol. 10
Abstract
No abstract availableFunding Information
- Ministerstvo Školství, Mládeže a Tělovýchovy (MUNI/A/1819/2025)
- Ministerstvo Školství, Mládeže a Tělovýchovy (MUNI/A/1906/2025)
This publication has 18 references indexed in Scilit:
- A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant SchizophreniaCNS Drugs, 2022
- Dried Blood Spot (DBS) as a useful tool to improve clozapine, aripiprazole and paliperidone treatment: From adherence to efficiencyRevista de Psiquiatría y Salud Mental, 2022
- Determination of clozapine and norclozapine in dried plasma spot and dried blood spot by liquid chromatography-tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2022
- Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogeneticsNeuropharmacology, 2020
- Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017Pharmacopsychiatry, 2017
- Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?Psychopharmacology, 2012
- Rapid assays of clozapine and its metabolites in dried blood spots by liquid chromatography and microextraction by packed sorbent procedureJournal of Chromatography A, 2011
- Pharmacogenetic prediction of clozapine responseThe Lancet, 2000
- Clinical profile of clozapine: Adverse reactions and agranulocytosisPsychiatric Quarterly, 1992
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988